Intravenous immunoglobulin-related thromboembolic events - an accusation that proves the opposite
Author:
- 29 December 2014
- journal article
- Published by Oxford University Press (OUP) in Clinical and Experimental Immunology
- Vol. 178 (S1) , 153-155
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Thromboembolic events associated with immunoglobulin treatmentVox Sanguinis, 2013
- Treatment With Intravenous Immunoglobulin and Steroids May Correct Severe Anemia in Hyperhemolytic Transfusion Reactions: Case Report and Literature ReviewTransfusion Medicine Reviews, 2010
- Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesionBlood, 2008
- Effects of Late Administration of Immunoglobulin on Experimental Atherosclerosis in Apolipoprotein E-Deficient MiceCirculation Journal, 2005
- Thromboembolic Complications of Intravenous Immunoglobulin TreatmentEuropean Neurology, 2004
- The clinical features of 16 cases of stroke associated with administration of IVIgNeurology, 2003
- F(ab)′2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulinsNature Medicine, 2003
- Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.Journal of Clinical Investigation, 1998
- High‐dose intravenous immunoglobulin and serum viscosityNeurology, 1994
- FATAL THROMBOTIC EVENTS DURING TREATMENT OF AUTOIMMUNE THROMBOCYTOPENIA WITH INTRAVENOUS IMMUNOGLOBULIN IN ELDERLY PATIENTSThe Lancet, 1986